Depression trials in Latvia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Jelgava, Liepaja, Siguldas Pagasts

  Age

  18 years and over

  People

  850 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06966401 · EU 2024-519423-24-00
• Phase 3Taking people
  NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Jelgava, Liepaja, Siguldas Pagasts

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06963021 · EU 2024-519421-37-00